Going natural – The most 'natural' thing to do

The Borneo Post - 1 day ago
Globally, it is a bustling...

St. Luke's Episcopal Church remodel opens doors

The Columbian - 5 days ago
The remodeling project increased...

Commitment of business leaders, entrepreneurs to recharge Detroit inspires ...

Crain's Detroit Business (blog) - 1 week ago
According to Girodat, it...

AuRico Gold Announces a New Gold-Copper Porphyry Discovery at the Kemess ...

Stockhouse - 6 days ago
The expanded 2015 drilling program...

Philly420: The unfortunate devolution of Pa.'s medical marijuana bill

Philly.com - 1 week ago
Cohen's vision for safe...

Doctor who founded Ohio Wildlife Center dead at 63

Columbus Dispatch - 4 weeks ago
Through the years, its services...

Written by CMMC

kxlo-klcm - 1 week ago
“CMMC's ambulance service...

Legalizing marijuana in Georgia

Atlanta Journal Constitution (blog) - 2 weeks ago
He's filed legislation that...

Receives high-grade gold results, including grades of 401Â g/t gold at Apollo ...

Stockhouse - 1 week ago
All results from the 2014 surface...

Obama awards Presidential Medal of Freedom to 18

SCNow - 4 weeks ago
Musician Stevie Wonder celebrates...

News via Google. See more news matching 'als expanded access'

 

Expanded Access

Bringing Research and Patients Together

Our Expanded Access platform is meant to do two things:

  1. Empower patients with access to new treatments that are in clinical research.
  2. Empower further research with clinical data from those patients.

For someone with a quick-killer disease, participating in clinical research may be the only way to access a new medicine that might help him live longer.  He may be willing to accept some uncertainty, considering the alternative.  So for patients, there’s a lot of overlap between treatment exploration and research.

But what about patients who cannot get into clinical trials?  Can they still take part in research and explore investigational treatment?

Yes, they can, but only through what are called Expanded Access programs (EAPs).  These are meant to include a much broader group of patients than traditional clinical trials, sometimes exclusively those patients who don’t meet clinical trial enrollment criteria or who otherwise cannot get into trials.

ALS-ETF is bringing a new kind of Expanded Access to the ALS community, to make a groundbreaking impact in the treatment landscape for patients as well as the research that’s powered by patient data.

Learn more about Expanded Access programs here.

Learn more about our research goals here.